Bioharvest Sciences (BHST) Net Cash Flow (2023 - 2025)

Bioharvest Sciences' Net Cash Flow history runs 3 years deep, the most recent figure standing at $12.0 million for Q4 2025.

• On a quarterly basis, Net Cash Flow rose 3688.96% year-over-year to $12.0 million in Q4 2025; TTM through Dec 2025 was $20.6 million, a 802.7% increase from a year earlier, with the FY2025 full-year figure at $20.6 million, up 802.7% from the prior year.
• Net Cash Flow rose to $12.0 million in Q4 2025 per BHST's latest filing, from $7.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $12.0 million in Q4 2025 and bottomed at -$2.4 million in Q3 2024.
• The 3-year median for Net Cash Flow is $676500.0 (2025), against an average of $2.1 million.
• Across the five-year window, Net Cash Flow sank 850.4% in 2024 and soared 3688.96% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $3.7 million in 2023, then slumped by 109.0% to -$335000.0 in 2024, then surged by 3688.96% to $12.0 million in 2025.
• Per Business Quant, the three latest BHST Net Cash Flow figures stand at $12.0 million (Q4 2025), $7.2 million (Q3 2025), and $338000.0 (Q2 2025).